JG
CRVS icon

Jain Global’s Corvus Pharmaceuticals CRVS Stock Holding History

Jain Global’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
+12,525
New +$174K ﹤0.01% 1537
2025
Q4 		– Sell
-27,618
Closed -$204K – 1271
2025
Q3 		$204K Buy
+27,618
New +$141K ﹤0.01% 898
2025
Q2 		– Sell
-48,145
Closed -$153K – 1261
2025
Q1 		$153K Buy
48,145
+31,545
+190% +$149K ﹤0.01% 912
2024
Q4 		$88.8K Buy
+16,600
New +$124K ﹤0.01% 694

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jain Global's CRVS Position: Q2 2026 in Review

Jain Global opened a new position in Corvus Pharmaceuticals (CRVS) in Q2 2026: 12,525 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #1537 among its holdings. This is a return to the name: Jain Global previously reported a position in CRVS as recently as Q3 2025.

Jain Global first reported a position in CRVS in Q4 2024 and has held it in 4 quarters since. The position peaked at $204K in Q3 2025. 174 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Jain Global held 12,525 shares of Corvus Pharmaceuticals worth $187K as of Q2 2026.
  • Corvus Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1537 holding.
  • Jain Global first reported a position in Corvus Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Corvus Pharmaceuticals position peaked at $204K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.